Individuals suffering from severe viral respiratory tract infections have recently emerged as
“at risk” groups for developing invasive fungal infections. Influenza virus is one of the most …

Summary COVID-19-associated pulmonary aspergillosis (CAPA) is defined as invasive
pulmonary aspergillosis occurring in COVID-19 patients. The purpose of this review was to …

Abstract During September–December 2020, we conducted a multicenter retrospective
study across India to evaluate epidemiology and outcomes among cases of coronavirus …

Background The prevalence of bacterial infection in patients with COVID-19 is low, however,
empiric antibiotic use is high. Risk stratification may be needed to minimize unnecessary …

Acute manifestations of SARS-CoV-2 infection continue to impact the lives of many across
the world. Post-acute sequelae of coronavirus disease 2019 (COVID-19) may affect 10–30 …

Purpose Invasive pulmonary aspergillosis has been increasingly recognized in COVID-19
patients, termed COVID-19-associate pulmonary aspergillosis (CAPA). Our meta-analysis …

Aim: This study aims to assess the changes in antimicrobial resistance among some critical
and high-priority microorganisms collected previously and during the coronavirus disease …

Long-term sequelae of coronavirus disease (COVID)-19 are frequent and of major concern.
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection affects the host …

Respiratory viruses represent a severe public health risk worldwide, and the research
contribution to tackle the current pandemic caused by the SARS-CoV-2 is one of the main …

Patients with viral infections are at higher risk to acquire bacterial and fungal superinfections
associated with a worse prognosis. We explored this critical point in the setting of patients …